Abstract
Low-dose treatment with acetylsalicylic acid (ASA) is widely recommended to type 2 diabetic patients as primary prevention against cardiovascular disease. High-dose treatment with cyclooxygenase inhibitors reduces urinary albumin excretion rate (AER) in type 1 diabetic patients with micro- or macroalbuminuria. Whether a similar effect on AER exists during low-dose ASA treatment, which may confound the diagnosis and monitoring of micro- and macroalbuminuria in type 2 diabetic patients, remains to be elucidated.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Nephrology, Dialysis, Transplantation |
Vol/bind | 18 |
Udgave nummer | 3 |
Sider (fra-til) | 539-42 |
Antal sider | 4 |
ISSN | 0931-0509 |
Status | Udgivet - 2003 |